Ken Takeuchi

3.4k total citations
62 papers, 2.2k citations indexed

About

Ken Takeuchi is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Ken Takeuchi has authored 62 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 24 papers in Epidemiology and 21 papers in Immunology. Recurrent topics in Ken Takeuchi's work include Inflammatory Bowel Disease (35 papers), Microscopic Colitis (22 papers) and Helicobacter pylori-related gastroenterology studies (7 papers). Ken Takeuchi is often cited by papers focused on Inflammatory Bowel Disease (35 papers), Microscopic Colitis (22 papers) and Helicobacter pylori-related gastroenterology studies (7 papers). Ken Takeuchi collaborates with scholars based in Japan, United States and United Kingdom. Ken Takeuchi's co-authors include Hiroyuki Hanai, Takayuki Iida, Abby R. Saniabadi, Fumitoshi Watanabe, Yasushi Iwaoka, Iwao Takanami, Masami Yamada, Yoshihiko Sato, Ingvar Bjarnason and Isao Matsushita and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer.

In The Last Decade

Ken Takeuchi

60 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Takeuchi Japan 23 1.2k 749 674 398 351 62 2.2k
Wu Zhen Dong United Kingdom 3 1.6k 1.3× 1.1k 1.4× 598 0.9× 620 1.6× 661 1.9× 7 2.6k
Imke Atreya Germany 26 1.0k 0.8× 443 0.6× 1.4k 2.1× 671 1.7× 427 1.2× 71 2.7k
Irene Marafini Italy 29 788 0.7× 431 0.6× 814 1.2× 951 2.4× 526 1.5× 102 2.5k
Massimiliano Sarra Italy 29 1.1k 0.9× 634 0.8× 2.0k 3.0× 774 1.9× 538 1.5× 50 3.5k
Jakob Benedict Seidelin Denmark 28 984 0.8× 651 0.9× 684 1.0× 666 1.7× 560 1.6× 140 2.3k
Davide Di Fusco Italy 23 398 0.3× 252 0.3× 682 1.0× 880 2.2× 258 0.7× 53 2.1k
Wen Zhou China 25 615 0.5× 449 0.6× 244 0.4× 658 1.7× 232 0.7× 110 1.9k
Ken‐ichi Katsu Japan 25 460 0.4× 326 0.4× 375 0.6× 686 1.7× 745 2.1× 106 2.2k
Qingdong Guan Canada 17 591 0.5× 286 0.4× 531 0.8× 609 1.5× 278 0.8× 34 1.6k
Daniela Vogl Germany 18 554 0.5× 210 0.3× 679 1.0× 489 1.2× 403 1.1× 19 1.7k

Countries citing papers authored by Ken Takeuchi

Since Specialization
Citations

This map shows the geographic impact of Ken Takeuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Takeuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Takeuchi more than expected).

Fields of papers citing papers by Ken Takeuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Takeuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Takeuchi. The network helps show where Ken Takeuchi may publish in the future.

Co-authorship network of co-authors of Ken Takeuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Takeuchi. A scholar is included among the top collaborators of Ken Takeuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Takeuchi. Ken Takeuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Panaccione, Remo, Édouard Louis, Jean‐Frédéric Colombel, et al.. (2024). P593 Efficacy of Risankizumab in Patients With Moderately to Severely Active Ulcerative Colitis by Prior Advanced Therapy Failure and Mechanism of Action: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies. Journal of Crohn s and Colitis. 18(Supplement_1). i1146–i1148. 1 indexed citations
3.
Hisamatsu, Tadakazu, Laurent Peyrin‐Biroulet, Axel Dignaß, et al.. (2024). P74 Improvement in inflammatory biomarkers through week-12 in guselkumab-treated patients with moderately-to-severely active ulcerative colitis: results from phase-3 QUASAR induction study. Poster presentations. A93–A94. 1 indexed citations
4.
Watanabe, Kenji, et al.. (2024). Impact of twice‐daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis. Journal of Gastroenterology and Hepatology. 39(11). 2367–2376. 1 indexed citations
5.
Vermeire, Séverine, Silvio Danese, G. D’Haens, et al.. (2023). OP04 Efficacy of upadacitinib in ulcerative colitis: A phase 3 post hoc analysis of biologic- and anti-TNF-inadequate response patients. Journal of Crohn s and Colitis. 17(Supplement_1). i8–i9. 2 indexed citations
6.
Vermeire, Séverine, J F Colombel, Ken Takeuchi, et al.. (2022). DOP38 Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1. Journal of Crohn s and Colitis. 16(Supplement_1). i087–i088. 10 indexed citations
7.
Loftus, Edward V., Jean‐Frédéric Colombel, Ken Takeuchi, et al.. (2022). Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment. Clinical Gastroenterology and Hepatology. 21(9). 2347–2358.e6. 60 indexed citations
8.
Yamamoto, Takayuki, Antonino Spinelli, Yasuo Suzuki, et al.. (2015). Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study. United European Gastroenterology Journal. 4(6). 784–793. 57 indexed citations
9.
10.
Hanai, Hiroyuki, Takayuki Iida, Ken Takeuchi, et al.. (2008). Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: An unblinded randomised multi-centre controlled study. Digestive and Liver Disease. 40(6). 433–440. 36 indexed citations
11.
Hanai, Hiroyuki, Takayuki Iida, Ken Takeuchi, et al.. (2006). Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial. Clinical Gastroenterology and Hepatology. 4(12). 1502–1506. 479 indexed citations
12.
Premchand, Purushothaman, Ken Takeuchi, & Ingvar Bjarnason. (2004). Granulocyte, macrophage, monocyte apheresis for refractory ulcerative proctitis. European Journal of Gastroenterology & Hepatology. 16(9). 943–945. 12 indexed citations
13.
Hanai, Hiroyuki, Fumitoshi Watanabe, Masami Yamada, et al.. (2004). Adsorptive Granulocyte and Monocyte Apheresis versus Prednisolone in Patients with Corticosteroid-Dependent Moderately Severe Ulcerative Colitis. Digestion. 70(1). 36–44. 114 indexed citations
14.
Saniabadi, Abby R., Hiroyuki Hanai, Ken Takeuchi, et al.. (2003). Adacolumn, an Adsorptive Carrier Based Granulocyte and MonocyteApheresis Device for the Treatment of Inflammatory and RefractoryDiseases Associated with Leukocytes. Therapeutic Apheresis and Dialysis. 7(1). 48–59. 209 indexed citations
15.
Hanai, Hiroyuki, et al.. (2002). CASE REPORT: Therapeutic Efficacy of Granulocyte and Monocyte Adsorption Apheresis in Severe Active Ulcerative Colitis. Digestive Diseases and Sciences. 47(10). 2349–2353. 69 indexed citations
16.
Takanami, Iwao, et al.. (2001). The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery. 121(6). 1058–1063. 133 indexed citations
17.
Takanami, Iwao, Ken Takeuchi, & Masao Naruke. (2000). Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer. 88(12). 2686–2692. 2 indexed citations
18.
Kodaira, Makoto, et al.. (1999). Functional muscarinic m3 receptor expressed in gastric cancer cells stimulates tyrosine phosphorylation and MAP kinase. Journal of Gastroenterology. 34(2). 163–171. 29 indexed citations
19.
Kajimura, Masayoshi, et al.. (1997). Expression of Muscarinic Receptor Subtypes (Effect of M3 Selective Antagonist on Gastric Motility and in Rat Gastric Smooth Muscle Emptying). Digestive Diseases and Sciences. 42(5). 907–914. 32 indexed citations
20.
Takeuchi, Ken, et al.. (1997). HISTOLOGICAL STUDY OF URINARY BLADDER TRANSPLANTATION IN RATS1. Transplantation. 63(7). 922–926. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wu Zhen Dong Breakdown of academic impact, for papers by Imke Atreya Breakdown of academic impact, for papers by Irene Marafini Breakdown of academic impact, for papers by Massimiliano Sarra Breakdown of academic impact, for papers by Jakob Benedict Seidelin Breakdown of academic impact, for papers by Davide Di Fusco Breakdown of academic impact, for papers by Wen Zhou Breakdown of academic impact, for papers by Ken‐ichi Katsu Breakdown of academic impact, for papers by Qingdong Guan Breakdown of academic impact, for papers by Daniela Vogl
Rankless by CCL
2026